"Innovators" relieved, Generics companies frustrated as government drops generic substitution plans for England
This article was originally published in Scrip
The new UK coalition government has dropped plans to introduce automatic generic substitution in England because of uncertainty over whether the government's proposals would have provided real benefit to the National Health Service (NHS), says the Department of Health (DoH). Some parts of the pharmaceutical industry appeared to be relieved, but generics producers were frustrated.
You may also be interested in...
Financial ties between companies and healthcare bodies distort the production and use of evidence, claims a paper co-authored by researchers, clinicians and decision makers, including a representative of Germany’s HTA body, IQWiG.
Meindert Boysen, head of NICE’s Centre For Health Technology Evaluation, shares advice for companies aiming to get their medicine to patients. His golden rules: engage in early advice and be more realistic about pricing.